Does prolonged oral treatment with sustained-release morphine tablets influence immune function?

Anesthesia and Analgesia

Volumn 86, Issue 1, 1998, Pages 166-172

  Palm, Sebastian ^a   Lehzen, Stephan ^a   Mignat, Christian ^a   Steinmann, Joerg ^a   Leimenstoll, Gerd ^a   Maier, Christoph ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLUTETHIMIDE; AMITRIPTYLINE; BACLOFEN; DEXAMETHASONE; DIPYRONE; FLUPIRTINE; HYDROCORTISONE; LEVOMEPROMAZINE; METOCLOPRAMIDE; MORPHINE; PROMETHAZINE; RANITIDINE; TAMOXIFEN; THEOPHYLLINE;

ADULT; ANALYTIC METHOD; ARTICLE; CLINICAL ARTICLE; CYTOTOXIC T LYMPHOCYTE; DRUG EFFECT; FEMALE; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; MALE; MONONUCLEAR CELL; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; STEM CELL; SUSTAINED RELEASE PREPARATION; T LYMPHOCYTE ACTIVATION;

ADMINISTRATION, ORAL; ADULT; AGED; CELLS, CULTURED; DELAYED-ACTION PREPARATIONS; FEMALE; HUMANS; IMMUNITY; IMMUNOGLOBULIN M; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MORPHINE;

EID: 0031985524     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199801000-00033     Document Type: Article

References (25)

1. Rouveix B. Opiates and immune function. Therapie 1992;47: 503-12.
2. Boukoms AJ, Masand P, Murray GB, et al. Chronic nonmalignant pain treated with long-term oral narcotic analgesics. Ann Clin Psychol 1992;4:185-91.
3. Calabrese JR, Klink MA, Gold PW. Alterations in immunocompetence during stress, bereavement and depression: focus on neuroendocrine regulation. Am J Psychiatry 1987;144: 1123-34.
4. Kato K. Characteristics of natural and recombinant human interleukin 2. In: Smith KA, ed. Interleukin 2. San Diego: Academic Press, 1988:37-66.
5. Bocchini G, Bonanno G, Canevari A. Influence of morphine and naloxone on human peripheral blood T-lymphocytes. Drug Alcohol Depend 1983;11:233-7.
6. Thomas PT, Bhargava HN, House RV. Immunomodulatory effects of in vitro exposure to morphine and its metabolites. Pharmacology 1995;50:51-62.
7. Lockwood LL, Silbert LH, Fleshner M, et al. Morphine-induced decreases in vivo antibody responses. Brain Behav Immunol 1994;8:24-36.
8. Bryant HU, Bernton EW, Holaday JW. Morphine pellet-induced immunomodulation in mice: temporal relationships. J Pharmacol Exp Ther 1988;245:913-20.
9. Bayer BM, Brehio RM, Ding XZ, Hernandez MC. Enhanced susceptibility of the immune system to stress in morphine-tolerant rats. Brain Behav Immunol 1994;8:173-84.
10. Louria DB, Hensle T, Rose J. The major medical complications of heroin addiction. Ann Intern Med 1967;67:1-22.
11. Maier C, Hildebrandt J, Klinger R, et al. Efficacy of oral morphine in chronic non-malignant pain (MONTAS). In: Abstracts of the 8th World Congress on Pain. Vancouver, BC: IASP Press, 1996:50.
12. Thomas L. Labor und Diagnose. 3rd ed. Marburg: Die Medizinische Verlagsgesellschaft, 1988.
13. Pasternak GW, Bodnar RJ, Clark JA, Inturrisi CE. Morphine-6-glucuronide a potent mu agonist. Life Sci 1987;41:2845-9.
14. Svensson JO, Rane A, Säwe J, Sjöquist F. Determination of morphine, morphine-3-glucuronide and (tentatively) morphine-6-glucuronide in plasma and urine using ion-pair high-performance liquid chromatography. J Chromatogr 1982;230: 427-32.
15. Mignat C, Jansen R, Ziegler A. Plasma and cerebrospinal fluid concentrations in rabbits receiving single and repeated doses of morphine. J Pharm Pharmacol 1995;47:171-5.
16. Caldwell CW, Taylor NM. A rapid no-wash for immunophenotypic analysis by flow cytometry. Am J Clin Pathol 1986;86:600.
17. Palm S, Mignat C, Kuhn K, et al. Phytohemagglutinin-dependent T-cell proliferation is not impaired by morphine. Methods Fund Exp Pharmacol 1996;18:159-65.
18. Williamson DF, Parker RA, Kendrick JS. The box plot: a simple visual method to interpret data. Ann Intern Med 1989;110: 916-21.
19. Portenoy RK, Foley KM, Stulman J, et al. Plasma morphine and morphine-6-glucuronide during chronic morphine therapy for cancer pain: plasma profiles, steady-state concentrations and the consequence of renal failure. Pain 1991;47:13-9.
20. Herzberg U, Murtaugh M, Beitz AJ. Chronic pain and immunity: mononeuropathy alters immune responses in rats. Pain 1994;59:219-25.
21. Sacerdote PA, Manfredi B, Bianchi M, Panerai AE. Intermittent but not continuous inescapable footshock stress affects immune responses and immunocyte β-endorphin concentrations in the rat. Brain Behav Immunol 1994;8:251-60.
22. Weiss JM, Sundar SK, Becker KJ, Cierpial MA. Behavioral and neural influences on cellular immune responses: effects of stress and interleukin 1. J Clin Psychiatry 1989;50:43-53.
23. Bhargava HN, Thomas PT, Thorat S, House RV. Effects of morphine tolerance and abstinence on cellular immune function. Brain Res 1994;642:1-10.
24. Coussons-Read ME, Dykstra LA, Lysle DT. Pavlovian conditioning of morphine-induced alterations of immune status: evidence for opioid receptor involvement. J Neuroimmunol 1994; 55:135-42.
25. Uchiyama T. Abnormal interleukin 2 receptor expression in adult T cell leukemia. In: Smith KA, ed. Interleukin 2. San Diego: Academic Press, 1988:179.